24 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified … , reputational harm, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight … , damages, fines, disgorgement, reputational harm, additional reporting obligations and oversight if we become subject to a corporate integrity agreement
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
to the Audit Committee, including the matters required to be discussed by the Public Company Accounting Oversight Board (“PCAOB”) and the SEC.
The Company’s … tend to receive repetitive or duplicative communications.
Board Leadership Structure and Role in Risk Oversight
Our Amended and Restated Bylaws
S-3
EX-1.2
okj41gywk2p86m3
12 Nov 21
Shelf registration
12:00am
S-3
h5djh8f0ai17vs16cjew
12 Nov 21
Shelf registration
12:00am
DEF 14A
0p345 h9s2q
26 Apr 21
Definitive proxy
5:00pm
10-K
fgmwctfjbut lo
18 Mar 21
Annual report
6:31am
424B4
1v7teb44oj f76kc77
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
zwt54bo6mnxrhcw
1 Feb 21
Draft registration statement
12:00am
10-Q
xnb6 108uoc5tw
10 Dec 20
Quarterly report
4:46pm
424B4
527x6z
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
EX-10.7
ein4c8 ze7e4j
9 Oct 20
IPO registration
4:59pm
S-1
zrd4 bqk31
9 Oct 20
IPO registration
4:59pm